Fibrocell Science (FCSC) Tops Q3 EPS by 36c

Fibrocell Science (NASDAQ: FCSC) reported Q3 EPS of ($0.02), $0.36 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Fibrocell Science (FCSC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M